Clinical Trial Update: FOCALFLEX (CE Mark) Study [NA]

View source ↗

Summary

The FOCALFLEX CE Mark study from Abbott Medical Devices for paroxysmal atrial fibrillation has completed, providing data to support CE marking.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation Paroxysmal | NA | Status: COMPLETED